The California Nuclear Moratorium and Breast Cancer Treatment

Over at Pajamas Media, Dr. Linda Halderman writes about the connection.

Comments

Anonymous said…

Nice try, but isotopes and other radioactive products for medical treatment are not produced in commercial power reactors.

January 18, 2008 at 12:44 PM

Anonymous said…

General Atomics wanted to build a medical isotope production reactor in San Diego circa 1996.

Their efforts were stopped at the planning stage by California's ban on new nuclear reactors, whether commercial power, research or isotope production.

Brookhaven National Labs (northern Long Island) also could have produced the isotopes, but their isotope production reactors were shut down to mollify anti-nukes by the Clinton Administration.

-Matthew B

January 20, 2008 at 11:56 PM

Anonymous said…

I had a business proposal for a private medical isotope production reactor and separation facility shot down by local anti-nuclear opposition. It was to be sited at a DOE site undergoing decomissioning and "redevelopment". It would have employed scores of highly skilled individuals with high-paying jobs, supplying products that are vital to the national health care system, and literally save thousands of lives each year. But that didn't take precedence over anti-nuclear hysteria.

January 21, 2008 at 2:53 PM

Fluor Invests in NuScale

You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...

Wednesday Update

From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...

NEI Nuclear Notes

Search This Blog